Recently, CCNB1 was used to build an mRNA risk signature to predict the prognosis of HCC [28], and AURKA was also involved in a 24 mRNA-based signature for early relapse prediction of HCC [6]. This evidence concerns the gene AURKA and hepatocellular carcinoma.